Novo vs. KBP: How a $1.3B deal turned into an international legal fight

Deals

american tariffs and US flag on yellow caution line i
Biotech

‘Let that one go’: Nkarta CEO urges US gov to drop China policies

Restrictions on Chinese science hurt the people that matter most—the patients—Nkarta CEO Paul Hastings told Fierce.
Gabrielle Masson Oct 16, 2025 2:00pm
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Dianthus offers up to $1B for China biotech’s autoimmune asset

Oct 16, 2025 10:57am
arrow target quiver aim shoot ammo

AstraZeneca pens fresh IBD collab with Immunai worth $85M

Oct 16, 2025 9:00am
Three blocks displaying from left to right a person a handshake and another person

BioCryst inks $700M Astria deal to rival Takeda in rare disease

Oct 14, 2025 10:30am
Torley
Favicon Fierce Pharma

Halozyme CEO targets new deals as IRA uncertainty subsides

Oct 14, 2025 9:40am
Wood shavings and chisels on a workbench

Takeda turns to AI drug designer after whittling down R&D focus

Oct 14, 2025 5:00am